nodes	percent_of_prediction	percent_of_DWPC	metapath
Azithromycin—CYP2A6—esophageal cancer	0.598	0.729	CbGaD
Azithromycin—ABCB1—esophageal cancer	0.223	0.271	CbGaD
Azithromycin—Congenital anomaly—Capecitabine—esophageal cancer	0.0016	0.0147	CcSEcCtD
Azithromycin—Enteritis—Methotrexate—esophageal cancer	0.00132	0.0122	CcSEcCtD
Azithromycin—Swelling face—Capecitabine—esophageal cancer	0.00127	0.0117	CcSEcCtD
Azithromycin—Troleandomycin—CYP2A6—esophageal cancer	0.00124	0.393	CrCbGaD
Azithromycin—Mucosal inflammation—Capecitabine—esophageal cancer	0.0011	0.0101	CcSEcCtD
Azithromycin—Hepatotoxicity—Cisplatin—esophageal cancer	0.00107	0.00981	CcSEcCtD
Azithromycin—Platelet count decreased—Capecitabine—esophageal cancer	0.00102	0.00939	CcSEcCtD
Azithromycin—Infection—Carboplatin—esophageal cancer	0.000995	0.00916	CcSEcCtD
Azithromycin—Oral candidiasis—Capecitabine—esophageal cancer	0.000955	0.00879	CcSEcCtD
Azithromycin—Extravasation—Cisplatin—esophageal cancer	0.000944	0.00868	CcSEcCtD
Azithromycin—Haemoglobin decreased—Capecitabine—esophageal cancer	0.000882	0.00812	CcSEcCtD
Azithromycin—Torsade de pointes—Capecitabine—esophageal cancer	0.000865	0.00796	CcSEcCtD
Azithromycin—Hearing impaired—Cisplatin—esophageal cancer	0.000865	0.00796	CcSEcCtD
Azithromycin—Pain—Carboplatin—esophageal cancer	0.000856	0.00788	CcSEcCtD
Azithromycin—Blister—Capecitabine—esophageal cancer	0.000842	0.00775	CcSEcCtD
Azithromycin—Mucosal inflammation—Methotrexate—esophageal cancer	0.000816	0.00751	CcSEcCtD
Azithromycin—Pleural effusion—Capecitabine—esophageal cancer	0.000793	0.00729	CcSEcCtD
Azithromycin—Body temperature increased—Carboplatin—esophageal cancer	0.000792	0.00729	CcSEcCtD
Azithromycin—Fungal infection—Capecitabine—esophageal cancer	0.000786	0.00723	CcSEcCtD
Azithromycin—Hepatotoxicity—Capecitabine—esophageal cancer	0.000786	0.00723	CcSEcCtD
Azithromycin—Otitis media—Capecitabine—esophageal cancer	0.00078	0.00717	CcSEcCtD
Azithromycin—Injection site pain—Capecitabine—esophageal cancer	0.000743	0.00684	CcSEcCtD
Azithromycin—Eye irritation—Capecitabine—esophageal cancer	0.000711	0.00654	CcSEcCtD
Azithromycin—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000672	0.00618	CcSEcCtD
Azithromycin—Skin discolouration—Capecitabine—esophageal cancer	0.000672	0.00618	CcSEcCtD
Azithromycin—Deafness—Cisplatin—esophageal cancer	0.000668	0.00615	CcSEcCtD
Azithromycin—Nasal congestion—Cisplatin—esophageal cancer	0.000656	0.00604	CcSEcCtD
Azithromycin—Renal failure acute—Cisplatin—esophageal cancer	0.000647	0.00596	CcSEcCtD
Azithromycin—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000642	0.0059	CcSEcCtD
Azithromycin—Hearing impaired—Capecitabine—esophageal cancer	0.000638	0.00587	CcSEcCtD
Azithromycin—Inflammation—Capecitabine—esophageal cancer	0.000626	0.00576	CcSEcCtD
Azithromycin—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000607	0.00559	CcSEcCtD
Azithromycin—Hyponatraemia—Cisplatin—esophageal cancer	0.0006	0.00552	CcSEcCtD
Azithromycin—Roxithromycin—ABCB1—esophageal cancer	0.000599	0.19	CrCbGaD
Azithromycin—Melaena—Capecitabine—esophageal cancer	0.000593	0.00546	CcSEcCtD
Azithromycin—Pleural effusion—Methotrexate—esophageal cancer	0.00059	0.00543	CcSEcCtD
Azithromycin—Fungal infection—Methotrexate—esophageal cancer	0.000585	0.00538	CcSEcCtD
Azithromycin—Hepatotoxicity—Methotrexate—esophageal cancer	0.000585	0.00538	CcSEcCtD
Azithromycin—Candida infection—Capecitabine—esophageal cancer	0.000579	0.00533	CcSEcCtD
Azithromycin—Face oedema—Cisplatin—esophageal cancer	0.000577	0.00531	CcSEcCtD
Azithromycin—Irritability—Cisplatin—esophageal cancer	0.00057	0.00525	CcSEcCtD
Azithromycin—Dry eye—Capecitabine—esophageal cancer	0.000561	0.00516	CcSEcCtD
Azithromycin—Dehydration—Cisplatin—esophageal cancer	0.000556	0.00511	CcSEcCtD
Azithromycin—Oesophagitis—Capecitabine—esophageal cancer	0.000555	0.0051	CcSEcCtD
Azithromycin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000538	0.00495	CcSEcCtD
Azithromycin—Nasopharyngitis—Cisplatin—esophageal cancer	0.000534	0.00492	CcSEcCtD
Azithromycin—Abnormal vision—Capecitabine—esophageal cancer	0.000529	0.00487	CcSEcCtD
Azithromycin—Extravasation—Methotrexate—esophageal cancer	0.000518	0.00477	CcSEcCtD
Azithromycin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000507	0.00466	CcSEcCtD
Azithromycin—Pancreatitis—Cisplatin—esophageal cancer	0.000506	0.00466	CcSEcCtD
Azithromycin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000504	0.00464	CcSEcCtD
Azithromycin—Photosensitivity—Capecitabine—esophageal cancer	0.000502	0.00462	CcSEcCtD
Azithromycin—Skin discolouration—Methotrexate—esophageal cancer	0.0005	0.0046	CcSEcCtD
Azithromycin—Swelling—Capecitabine—esophageal cancer	0.000499	0.0046	CcSEcCtD
Azithromycin—Gastroenteritis—Capecitabine—esophageal cancer	0.000497	0.00457	CcSEcCtD
Azithromycin—Deafness—Capecitabine—esophageal cancer	0.000492	0.00453	CcSEcCtD
Azithromycin—Hepatic failure—Capecitabine—esophageal cancer	0.00049	0.00451	CcSEcCtD
Azithromycin—Eye pain—Capecitabine—esophageal cancer	0.000488	0.00449	CcSEcCtD
Azithromycin—Renal failure acute—Capecitabine—esophageal cancer	0.000477	0.00439	CcSEcCtD
Azithromycin—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000467	0.0043	CcSEcCtD
Azithromycin—Inflammation—Methotrexate—esophageal cancer	0.000466	0.00429	CcSEcCtD
Azithromycin—Vasculitis—Methotrexate—esophageal cancer	0.000463	0.00426	CcSEcCtD
Azithromycin—Dermatitis bullous—Capecitabine—esophageal cancer	0.000461	0.00424	CcSEcCtD
Azithromycin—Troleandomycin—ABCB1—esophageal cancer	0.00046	0.146	CrCbGaD
Azithromycin—Clarithromycin—ABCB1—esophageal cancer	0.000454	0.144	CrCbGaD
Azithromycin—Vaginal inflammation—Methotrexate—esophageal cancer	0.000452	0.00416	CcSEcCtD
Azithromycin—Stomatitis—Cisplatin—esophageal cancer	0.000449	0.00413	CcSEcCtD
Azithromycin—Hyponatraemia—Capecitabine—esophageal cancer	0.000442	0.00407	CcSEcCtD
Azithromycin—Melaena—Methotrexate—esophageal cancer	0.000441	0.00406	CcSEcCtD
Azithromycin—Vaginal infection—Methotrexate—esophageal cancer	0.000427	0.00393	CcSEcCtD
Azithromycin—Face oedema—Capecitabine—esophageal cancer	0.000425	0.00391	CcSEcCtD
Azithromycin—Irritability—Capecitabine—esophageal cancer	0.00042	0.00387	CcSEcCtD
Azithromycin—Dehydration—Capecitabine—esophageal cancer	0.00041	0.00377	CcSEcCtD
Azithromycin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000407	0.00374	CcSEcCtD
Azithromycin—Abdominal pain upper—Capecitabine—esophageal cancer	0.000402	0.0037	CcSEcCtD
Azithromycin—Erythromycin—ABCB1—esophageal cancer	0.000399	0.127	CrCbGaD
Azithromycin—Visual impairment—Cisplatin—esophageal cancer	0.000398	0.00367	CcSEcCtD
Azithromycin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000397	0.00365	CcSEcCtD
Azithromycin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000397	0.00365	CcSEcCtD
Azithromycin—Nasopharyngitis—Capecitabine—esophageal cancer	0.000394	0.00363	CcSEcCtD
Azithromycin—Gastritis—Capecitabine—esophageal cancer	0.00039	0.00359	CcSEcCtD
Azithromycin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000389	0.00358	CcSEcCtD
Azithromycin—Tinnitus—Cisplatin—esophageal cancer	0.000385	0.00355	CcSEcCtD
Azithromycin—Influenza—Capecitabine—esophageal cancer	0.000381	0.0035	CcSEcCtD
Azithromycin—Asthma—Capecitabine—esophageal cancer	0.000381	0.0035	CcSEcCtD
Azithromycin—Bronchospasm—Capecitabine—esophageal cancer	0.000375	0.00345	CcSEcCtD
Azithromycin—Photosensitivity—Methotrexate—esophageal cancer	0.000373	0.00344	CcSEcCtD
Azithromycin—Arrhythmia—Cisplatin—esophageal cancer	0.000369	0.0034	CcSEcCtD
Azithromycin—Hepatic failure—Methotrexate—esophageal cancer	0.000365	0.00336	CcSEcCtD
Azithromycin—Dysuria—Capecitabine—esophageal cancer	0.000356	0.00328	CcSEcCtD
Azithromycin—Neutropenia—Capecitabine—esophageal cancer	0.000356	0.00328	CcSEcCtD
Azithromycin—Renal failure acute—Methotrexate—esophageal cancer	0.000355	0.00327	CcSEcCtD
Azithromycin—Flatulence—Cisplatin—esophageal cancer	0.000355	0.00326	CcSEcCtD
Azithromycin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000348	0.0032	CcSEcCtD
Azithromycin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000348	0.0032	CcSEcCtD
Azithromycin—Pneumonia—Capecitabine—esophageal cancer	0.000341	0.00314	CcSEcCtD
Azithromycin—Infestation NOS—Capecitabine—esophageal cancer	0.00034	0.00312	CcSEcCtD
Azithromycin—Infestation—Capecitabine—esophageal cancer	0.00034	0.00312	CcSEcCtD
Azithromycin—Vision blurred—Cisplatin—esophageal cancer	0.000339	0.00312	CcSEcCtD
Azithromycin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000337	0.0031	CcSEcCtD
Azithromycin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000334	0.00307	CcSEcCtD
Azithromycin—Anaemia—Cisplatin—esophageal cancer	0.000333	0.00306	CcSEcCtD
Azithromycin—Stomatitis—Capecitabine—esophageal cancer	0.000331	0.00305	CcSEcCtD
Azithromycin—Jaundice—Capecitabine—esophageal cancer	0.000331	0.00305	CcSEcCtD
Azithromycin—Malaise—Cisplatin—esophageal cancer	0.000325	0.00299	CcSEcCtD
Azithromycin—Leukopenia—Cisplatin—esophageal cancer	0.000322	0.00296	CcSEcCtD
Azithromycin—Irritability—Methotrexate—esophageal cancer	0.000313	0.00288	CcSEcCtD
Azithromycin—Convulsion—Cisplatin—esophageal cancer	0.000312	0.00287	CcSEcCtD
Azithromycin—Myalgia—Cisplatin—esophageal cancer	0.000306	0.00282	CcSEcCtD
Azithromycin—Rhinitis—Capecitabine—esophageal cancer	0.000306	0.00281	CcSEcCtD
Azithromycin—Anxiety—Cisplatin—esophageal cancer	0.000305	0.00281	CcSEcCtD
Azithromycin—Hepatitis—Capecitabine—esophageal cancer	0.000305	0.0028	CcSEcCtD
Azithromycin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000303	0.00279	CcSEcCtD
Azithromycin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000303	0.00279	CcSEcCtD
Azithromycin—Discomfort—Cisplatin—esophageal cancer	0.000303	0.00279	CcSEcCtD
Azithromycin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000295	0.00272	CcSEcCtD
Azithromycin—Oedema—Cisplatin—esophageal cancer	0.000294	0.0027	CcSEcCtD
Azithromycin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000294	0.0027	CcSEcCtD
Azithromycin—Visual impairment—Capecitabine—esophageal cancer	0.000294	0.0027	CcSEcCtD
Azithromycin—Infection—Cisplatin—esophageal cancer	0.000292	0.00269	CcSEcCtD
Azithromycin—Erythema multiforme—Capecitabine—esophageal cancer	0.000288	0.00265	CcSEcCtD
Azithromycin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000288	0.00265	CcSEcCtD
Azithromycin—Tinnitus—Capecitabine—esophageal cancer	0.000284	0.00262	CcSEcCtD
Azithromycin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000284	0.00261	CcSEcCtD
Azithromycin—Asthma—Methotrexate—esophageal cancer	0.000283	0.00261	CcSEcCtD
Azithromycin—Eosinophilia—Methotrexate—esophageal cancer	0.000281	0.00258	CcSEcCtD
Azithromycin—Anorexia—Cisplatin—esophageal cancer	0.00028	0.00258	CcSEcCtD
Azithromycin—Pancreatitis—Methotrexate—esophageal cancer	0.000278	0.00256	CcSEcCtD
Azithromycin—Hypotension—Cisplatin—esophageal cancer	0.000274	0.00253	CcSEcCtD
Azithromycin—Chills—Capecitabine—esophageal cancer	0.000273	0.00252	CcSEcCtD
Azithromycin—Arrhythmia—Capecitabine—esophageal cancer	0.000272	0.00251	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000268	0.00246	CcSEcCtD
Azithromycin—Dysuria—Methotrexate—esophageal cancer	0.000265	0.00244	CcSEcCtD
Azithromycin—Neutropenia—Methotrexate—esophageal cancer	0.000265	0.00244	CcSEcCtD
Azithromycin—Paraesthesia—Cisplatin—esophageal cancer	0.000264	0.00243	CcSEcCtD
Azithromycin—Dyspnoea—Cisplatin—esophageal cancer	0.000262	0.00241	CcSEcCtD
Azithromycin—Flatulence—Capecitabine—esophageal cancer	0.000261	0.00241	CcSEcCtD
Azithromycin—Dysgeusia—Capecitabine—esophageal cancer	0.00026	0.00239	CcSEcCtD
Azithromycin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000259	0.00238	CcSEcCtD
Azithromycin—Decreased appetite—Cisplatin—esophageal cancer	0.000255	0.00235	CcSEcCtD
Azithromycin—Pneumonia—Methotrexate—esophageal cancer	0.000254	0.00234	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000254	0.00233	CcSEcCtD
Azithromycin—Infestation NOS—Methotrexate—esophageal cancer	0.000253	0.00233	CcSEcCtD
Azithromycin—Infestation—Methotrexate—esophageal cancer	0.000253	0.00233	CcSEcCtD
Azithromycin—Pain—Cisplatin—esophageal cancer	0.000251	0.00231	CcSEcCtD
Azithromycin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000251	0.00231	CcSEcCtD
Azithromycin—Vision blurred—Capecitabine—esophageal cancer	0.00025	0.0023	CcSEcCtD
Azithromycin—Stomatitis—Methotrexate—esophageal cancer	0.000246	0.00227	CcSEcCtD
Azithromycin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000246	0.00227	CcSEcCtD
Azithromycin—Anaemia—Capecitabine—esophageal cancer	0.000245	0.00226	CcSEcCtD
Azithromycin—Sweating—Methotrexate—esophageal cancer	0.000242	0.00223	CcSEcCtD
Azithromycin—Feeling abnormal—Cisplatin—esophageal cancer	0.000242	0.00223	CcSEcCtD
Azithromycin—Malaise—Capecitabine—esophageal cancer	0.000239	0.0022	CcSEcCtD
Azithromycin—Vertigo—Capecitabine—esophageal cancer	0.000238	0.00219	CcSEcCtD
Azithromycin—Syncope—Capecitabine—esophageal cancer	0.000238	0.00219	CcSEcCtD
Azithromycin—Leukopenia—Capecitabine—esophageal cancer	0.000237	0.00219	CcSEcCtD
Azithromycin—Palpitations—Capecitabine—esophageal cancer	0.000234	0.00216	CcSEcCtD
Azithromycin—Loss of consciousness—Capecitabine—esophageal cancer	0.000233	0.00215	CcSEcCtD
Azithromycin—Body temperature increased—Cisplatin—esophageal cancer	0.000232	0.00214	CcSEcCtD
Azithromycin—Cough—Capecitabine—esophageal cancer	0.000232	0.00213	CcSEcCtD
Azithromycin—Hypertension—Capecitabine—esophageal cancer	0.000229	0.00211	CcSEcCtD
Azithromycin—Hepatitis—Methotrexate—esophageal cancer	0.000227	0.00209	CcSEcCtD
Azithromycin—Chest pain—Capecitabine—esophageal cancer	0.000226	0.00208	CcSEcCtD
Azithromycin—Myalgia—Capecitabine—esophageal cancer	0.000226	0.00208	CcSEcCtD
Azithromycin—Arthralgia—Capecitabine—esophageal cancer	0.000226	0.00208	CcSEcCtD
Azithromycin—Anxiety—Capecitabine—esophageal cancer	0.000225	0.00207	CcSEcCtD
Azithromycin—Discomfort—Capecitabine—esophageal cancer	0.000223	0.00205	CcSEcCtD
Azithromycin—Dry mouth—Capecitabine—esophageal cancer	0.000221	0.00203	CcSEcCtD
Azithromycin—Visual impairment—Methotrexate—esophageal cancer	0.000219	0.00201	CcSEcCtD
Azithromycin—Oedema—Capecitabine—esophageal cancer	0.000217	0.00199	CcSEcCtD
Azithromycin—Hypersensitivity—Cisplatin—esophageal cancer	0.000216	0.00199	CcSEcCtD
Azithromycin—Infection—Capecitabine—esophageal cancer	0.000215	0.00198	CcSEcCtD
Azithromycin—Erythema multiforme—Methotrexate—esophageal cancer	0.000215	0.00197	CcSEcCtD
Azithromycin—Shock—Capecitabine—esophageal cancer	0.000213	0.00196	CcSEcCtD
Azithromycin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000212	0.00195	CcSEcCtD
Azithromycin—Tinnitus—Methotrexate—esophageal cancer	0.000212	0.00195	CcSEcCtD
Azithromycin—Asthenia—Cisplatin—esophageal cancer	0.000211	0.00194	CcSEcCtD
Azithromycin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000209	0.00193	CcSEcCtD
Azithromycin—Anorexia—Capecitabine—esophageal cancer	0.000206	0.0019	CcSEcCtD
Azithromycin—Chills—Methotrexate—esophageal cancer	0.000204	0.00187	CcSEcCtD
Azithromycin—Hypotension—Capecitabine—esophageal cancer	0.000202	0.00186	CcSEcCtD
Azithromycin—Diarrhoea—Cisplatin—esophageal cancer	0.000201	0.00185	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000197	0.00182	CcSEcCtD
Azithromycin—Insomnia—Capecitabine—esophageal cancer	0.000196	0.0018	CcSEcCtD
Azithromycin—Paraesthesia—Capecitabine—esophageal cancer	0.000194	0.00179	CcSEcCtD
Azithromycin—Dysgeusia—Methotrexate—esophageal cancer	0.000193	0.00178	CcSEcCtD
Azithromycin—Dyspnoea—Capecitabine—esophageal cancer	0.000193	0.00178	CcSEcCtD
Azithromycin—Dyspepsia—Capecitabine—esophageal cancer	0.000191	0.00175	CcSEcCtD
Azithromycin—Decreased appetite—Capecitabine—esophageal cancer	0.000188	0.00173	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000187	0.00172	CcSEcCtD
Azithromycin—Vomiting—Cisplatin—esophageal cancer	0.000187	0.00172	CcSEcCtD
Azithromycin—Fatigue—Capecitabine—esophageal cancer	0.000187	0.00172	CcSEcCtD
Azithromycin—Vision blurred—Methotrexate—esophageal cancer	0.000186	0.00171	CcSEcCtD
Azithromycin—Rash—Cisplatin—esophageal cancer	0.000185	0.0017	CcSEcCtD
Azithromycin—CYP1A2—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.000185	0.00273	CbGpPWpGaD
Azithromycin—Pain—Capecitabine—esophageal cancer	0.000185	0.0017	CcSEcCtD
Azithromycin—Constipation—Capecitabine—esophageal cancer	0.000185	0.0017	CcSEcCtD
Azithromycin—Dermatitis—Cisplatin—esophageal cancer	0.000185	0.0017	CcSEcCtD
Azithromycin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000183	0.00169	CcSEcCtD
Azithromycin—Anaemia—Methotrexate—esophageal cancer	0.000183	0.00168	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—GSTT1—esophageal cancer	0.000182	0.00268	CbGpPWpGaD
Azithromycin—Feeling abnormal—Capecitabine—esophageal cancer	0.000178	0.00164	CcSEcCtD
Azithromycin—Malaise—Methotrexate—esophageal cancer	0.000178	0.00164	CcSEcCtD
Azithromycin—Vertigo—Methotrexate—esophageal cancer	0.000177	0.00163	CcSEcCtD
Azithromycin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000177	0.00163	CcSEcCtD
Azithromycin—Leukopenia—Methotrexate—esophageal cancer	0.000177	0.00163	CcSEcCtD
Azithromycin—Nausea—Cisplatin—esophageal cancer	0.000174	0.00161	CcSEcCtD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000174	0.00257	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000173	0.00256	CbGpPWpGaD
Azithromycin—Cough—Methotrexate—esophageal cancer	0.000172	0.00159	CcSEcCtD
Azithromycin—Urticaria—Capecitabine—esophageal cancer	0.000172	0.00158	CcSEcCtD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000171	0.00252	CbGpPWpGaD
Azithromycin—Abdominal pain—Capecitabine—esophageal cancer	0.000171	0.00158	CcSEcCtD
Azithromycin—Body temperature increased—Capecitabine—esophageal cancer	0.000171	0.00158	CcSEcCtD
Azithromycin—Convulsion—Methotrexate—esophageal cancer	0.000171	0.00157	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—PTGS1—esophageal cancer	0.000171	0.00251	CbGpPWpGaD
Azithromycin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000168	0.00248	CbGpPWpGaD
Azithromycin—Arthralgia—Methotrexate—esophageal cancer	0.000168	0.00155	CcSEcCtD
Azithromycin—Chest pain—Methotrexate—esophageal cancer	0.000168	0.00155	CcSEcCtD
Azithromycin—Myalgia—Methotrexate—esophageal cancer	0.000168	0.00155	CcSEcCtD
Azithromycin—Discomfort—Methotrexate—esophageal cancer	0.000166	0.00153	CcSEcCtD
Azithromycin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000161	0.00148	CcSEcCtD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000161	0.00237	CbGpPWpGaD
Azithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00016	0.00236	CbGpPWpGaD
Azithromycin—Infection—Methotrexate—esophageal cancer	0.00016	0.00147	CcSEcCtD
Azithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00016	0.00236	CbGpPWpGaD
Azithromycin—Hypersensitivity—Capecitabine—esophageal cancer	0.00016	0.00147	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000159	0.00235	CbGpPWpGaD
Azithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000158	0.00233	CbGpPWpGaD
Azithromycin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000158	0.00145	CcSEcCtD
Azithromycin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000156	0.00143	CcSEcCtD
Azithromycin—Asthenia—Capecitabine—esophageal cancer	0.000155	0.00143	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.000154	0.00227	CbGpPWpGaD
Azithromycin—Anorexia—Methotrexate—esophageal cancer	0.000154	0.00141	CcSEcCtD
Azithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000153	0.00226	CbGpPWpGaD
Azithromycin—Pruritus—Capecitabine—esophageal cancer	0.000153	0.00141	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.000153	0.00225	CbGpPWpGaD
Azithromycin—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000153	0.00225	CbGpPWpGaD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000153	0.00225	CbGpPWpGaD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000151	0.00223	CbGpPWpGaD
Azithromycin—Hypotension—Methotrexate—esophageal cancer	0.000151	0.00139	CcSEcCtD
Azithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00015	0.00222	CbGpPWpGaD
Azithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000148	0.00219	CbGpPWpGaD
Azithromycin—Diarrhoea—Capecitabine—esophageal cancer	0.000148	0.00136	CcSEcCtD
Azithromycin—CYP1A2—Phase II conjugation—GSTT1—esophageal cancer	0.000148	0.00218	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—ADH7—esophageal cancer	0.000147	0.00217	CbGpPWpGaD
Azithromycin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000147	0.00135	CcSEcCtD
Azithromycin—Insomnia—Methotrexate—esophageal cancer	0.000146	0.00134	CcSEcCtD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000146	0.00215	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—CYP1B1—esophageal cancer	0.000145	0.00214	CbGpPWpGaD
Azithromycin—Paraesthesia—Methotrexate—esophageal cancer	0.000145	0.00133	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—TGFBR2—esophageal cancer	0.000144	0.00212	CbGpPWpGaD
Azithromycin—Dyspnoea—Methotrexate—esophageal cancer	0.000144	0.00132	CcSEcCtD
Azithromycin—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000144	0.00212	CbGpPWpGaD
Azithromycin—Somnolence—Methotrexate—esophageal cancer	0.000143	0.00132	CcSEcCtD
Azithromycin—Dizziness—Capecitabine—esophageal cancer	0.000143	0.00132	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—HMOX1—esophageal cancer	0.000142	0.00209	CbGpPWpGaD
Azithromycin—Dyspepsia—Methotrexate—esophageal cancer	0.000142	0.00131	CcSEcCtD
Azithromycin—Decreased appetite—Methotrexate—esophageal cancer	0.00014	0.00129	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000139	0.00128	CcSEcCtD
Azithromycin—Fatigue—Methotrexate—esophageal cancer	0.000139	0.00128	CcSEcCtD
Azithromycin—Pain—Methotrexate—esophageal cancer	0.000138	0.00127	CcSEcCtD
Azithromycin—Vomiting—Capecitabine—esophageal cancer	0.000138	0.00127	CcSEcCtD
Azithromycin—Rash—Capecitabine—esophageal cancer	0.000137	0.00126	CcSEcCtD
Azithromycin—Dermatitis—Capecitabine—esophageal cancer	0.000136	0.00126	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—CYP19A1—esophageal cancer	0.000136	0.00201	CbGpPWpGaD
Azithromycin—Headache—Capecitabine—esophageal cancer	0.000136	0.00125	CcSEcCtD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000135	0.00198	CbGpPWpGaD
Azithromycin—Feeling abnormal—Methotrexate—esophageal cancer	0.000133	0.00122	CcSEcCtD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000132	0.00195	CbGpPWpGaD
Azithromycin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000132	0.00121	CcSEcCtD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00013	0.00191	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—ADH1B—esophageal cancer	0.000129	0.0019	CbGpPWpGaD
Azithromycin—Nausea—Capecitabine—esophageal cancer	0.000129	0.00118	CcSEcCtD
Azithromycin—Urticaria—Methotrexate—esophageal cancer	0.000128	0.00118	CcSEcCtD
Azithromycin—Abdominal pain—Methotrexate—esophageal cancer	0.000127	0.00117	CcSEcCtD
Azithromycin—Body temperature increased—Methotrexate—esophageal cancer	0.000127	0.00117	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000125	0.00184	CbGpPWpGaD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000124	0.00183	CbGpPWpGaD
Azithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000124	0.00182	CbGpPWpGaD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000122	0.0018	CbGpPWpGaD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000122	0.0018	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP26A1—esophageal cancer	0.00012	0.00177	CbGpPWpGaD
Azithromycin—Hypersensitivity—Methotrexate—esophageal cancer	0.000119	0.00109	CcSEcCtD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000118	0.00174	CbGpPWpGaD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000118	0.00173	CbGpPWpGaD
Azithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000116	0.00171	CbGpPWpGaD
Azithromycin—Asthenia—Methotrexate—esophageal cancer	0.000116	0.00106	CcSEcCtD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000115	0.00169	CbGpPWpGaD
Azithromycin—Pruritus—Methotrexate—esophageal cancer	0.000114	0.00105	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000114	0.00168	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000114	0.00167	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	0.000112	0.00164	CbGpPWpGaD
Azithromycin—Diarrhoea—Methotrexate—esophageal cancer	0.00011	0.00101	CcSEcCtD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	0.00011	0.00162	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000109	0.0016	CbGpPWpGaD
Azithromycin—Dizziness—Methotrexate—esophageal cancer	0.000107	0.000981	CcSEcCtD
Azithromycin—Vomiting—Methotrexate—esophageal cancer	0.000102	0.000943	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000102	0.00151	CbGpPWpGaD
Azithromycin—Rash—Methotrexate—esophageal cancer	0.000102	0.000935	CcSEcCtD
Azithromycin—Dermatitis—Methotrexate—esophageal cancer	0.000102	0.000934	CcSEcCtD
Azithromycin—Headache—Methotrexate—esophageal cancer	0.000101	0.000929	CcSEcCtD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.0001	0.00148	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	9.96e-05	0.00147	CbGpPWpGaD
Azithromycin—Nausea—Methotrexate—esophageal cancer	9.57e-05	0.000881	CcSEcCtD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	9.41e-05	0.00139	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	9.26e-05	0.00136	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	9.16e-05	0.00135	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	9.13e-05	0.00135	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	9.09e-05	0.00134	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	8.92e-05	0.00131	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—CASP8—esophageal cancer	8.89e-05	0.00131	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	8.65e-05	0.00127	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	8.61e-05	0.00127	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	8.55e-05	0.00126	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	8.49e-05	0.00125	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	8.37e-05	0.00123	CbGpPWpGaD
Azithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	8.35e-05	0.00123	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	8.11e-05	0.00119	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	7.97e-05	0.00117	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	7.92e-05	0.00117	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	7.8e-05	0.00115	CbGpPWpGaD
Azithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	7.7e-05	0.00113	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.44e-05	0.0011	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	7.42e-05	0.00109	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	7.42e-05	0.00109	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—BLVRB—esophageal cancer	7.33e-05	0.00108	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—SLC52A3—esophageal cancer	7.33e-05	0.00108	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	7.06e-05	0.00104	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	7.02e-05	0.00103	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	6.96e-05	0.00103	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	6.89e-05	0.00102	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	6.8e-05	0.001	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	6.75e-05	0.000995	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.73e-05	0.000992	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	6.68e-05	0.000984	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	6.65e-05	0.000979	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	6.6e-05	0.000972	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	6.54e-05	0.000963	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	6.48e-05	0.000955	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	6.47e-05	0.000953	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.45e-05	0.000951	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.45e-05	0.000951	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	6.39e-05	0.000942	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	6.32e-05	0.000932	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	6.32e-05	0.000932	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.26e-05	0.000922	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CA1—esophageal cancer	6.23e-05	0.000918	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—SLC10A2—esophageal cancer	6.23e-05	0.000918	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	6.18e-05	0.000911	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CA2—esophageal cancer	5.7e-05	0.00084	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.32e-05	0.000784	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PLCE1—esophageal cancer	5.3e-05	0.000781	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ADH7—esophageal cancer	5.3e-05	0.000781	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.25e-05	0.000773	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	5e-05	0.000737	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	4.93e-05	0.000727	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.89e-05	0.000721	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ADH1B—esophageal cancer	4.65e-05	0.000685	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.49e-05	0.000662	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—TYMP—esophageal cancer	4.44e-05	0.000654	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.44e-05	0.000654	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	4.39e-05	0.000647	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	4.37e-05	0.000644	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—BLVRB—esophageal cancer	4.36e-05	0.000643	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—SLC52A3—esophageal cancer	4.36e-05	0.000643	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CYP26A1—esophageal cancer	4.32e-05	0.000636	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ALOX15—esophageal cancer	4.21e-05	0.00062	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTO1—esophageal cancer	4.02e-05	0.000592	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—TPI1—esophageal cancer	4.02e-05	0.000592	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.92e-05	0.000577	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ALDOB—esophageal cancer	3.85e-05	0.000567	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.77e-05	0.000555	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CA1—esophageal cancer	3.71e-05	0.000546	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.71e-05	0.000546	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GAPDH—esophageal cancer	3.71e-05	0.000546	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CRABP1—esophageal cancer	3.67e-05	0.000541	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.66e-05	0.000539	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.58e-05	0.000527	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GNG7—esophageal cancer	3.49e-05	0.000515	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.48e-05	0.000513	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.48e-05	0.000513	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CA2—esophageal cancer	3.39e-05	0.0005	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ALDH2—esophageal cancer	3.27e-05	0.000482	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.23e-05	0.000476	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PLCE1—esophageal cancer	3.15e-05	0.000465	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ADH7—esophageal cancer	3.15e-05	0.000465	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.13e-05	0.000461	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTT1—esophageal cancer	3.11e-05	0.000459	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.11e-05	0.000459	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.98e-05	0.000438	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.96e-05	0.000436	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CA1—esophageal cancer	2.96e-05	0.000436	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ENO1—esophageal cancer	2.92e-05	0.00043	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PTGS1—esophageal cancer	2.92e-05	0.00043	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PSME2—esophageal cancer	2.88e-05	0.000424	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PSME1—esophageal cancer	2.88e-05	0.000424	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ADH1B—esophageal cancer	2.76e-05	0.000407	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CA2—esophageal cancer	2.71e-05	0.000399	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.7e-05	0.000398	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.69e-05	0.000396	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.69e-05	0.000396	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.65e-05	0.00039	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—TYMP—esophageal cancer	2.64e-05	0.000389	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.59e-05	0.000382	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.57e-05	0.000379	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.54e-05	0.000374	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ADH7—esophageal cancer	2.52e-05	0.000371	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.52e-05	0.000371	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ALOX15—esophageal cancer	2.5e-05	0.000369	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.49e-05	0.000367	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2.48e-05	0.000366	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTO1—esophageal cancer	2.39e-05	0.000352	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—TPI1—esophageal cancer	2.39e-05	0.000352	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CYP19A1—esophageal cancer	2.33e-05	0.000344	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ALDOB—esophageal cancer	2.29e-05	0.000338	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CA1—esophageal cancer	2.28e-05	0.000337	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.28e-05	0.000337	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.21e-05	0.000325	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GAPDH—esophageal cancer	2.21e-05	0.000325	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.2e-05	0.000324	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CRABP1—esophageal cancer	2.19e-05	0.000322	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.13e-05	0.000314	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—HMOX1—esophageal cancer	2.13e-05	0.000314	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—TYMP—esophageal cancer	2.11e-05	0.000311	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CA2—esophageal cancer	2.09e-05	0.000308	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GNG7—esophageal cancer	2.08e-05	0.000306	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.05e-05	0.000302	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ABCB1—esophageal cancer	2.04e-05	0.000301	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ALOX15—esophageal cancer	2e-05	0.000295	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ALDH2—esophageal cancer	1.95e-05	0.000287	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ADH7—esophageal cancer	1.94e-05	0.000286	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.94e-05	0.000286	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—TPI1—esophageal cancer	1.91e-05	0.000281	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.91e-05	0.000281	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTT1—esophageal cancer	1.85e-05	0.000273	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.83e-05	0.00027	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.83e-05	0.000269	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.76e-05	0.000259	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.74e-05	0.000257	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PTGS1—esophageal cancer	1.74e-05	0.000256	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ENO1—esophageal cancer	1.74e-05	0.000256	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.73e-05	0.000256	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PSME2—esophageal cancer	1.71e-05	0.000252	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PSME1—esophageal cancer	1.71e-05	0.000252	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.7e-05	0.000251	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GNG7—esophageal cancer	1.66e-05	0.000245	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—TYMP—esophageal cancer	1.63e-05	0.00024	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.58e-05	0.000233	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.56e-05	0.000229	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.54e-05	0.000227	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.48e-05	0.000218	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.48e-05	0.000218	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—TPI1—esophageal cancer	1.47e-05	0.000217	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.47e-05	0.000217	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.46e-05	0.000215	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.46e-05	0.000215	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.41e-05	0.000208	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.39e-05	0.000205	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ENO1—esophageal cancer	1.39e-05	0.000204	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.39e-05	0.000204	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PSME2—esophageal cancer	1.37e-05	0.000201	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PSME1—esophageal cancer	1.37e-05	0.000201	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.37e-05	0.000201	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.36e-05	0.0002	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.35e-05	0.000198	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GNG7—esophageal cancer	1.28e-05	0.000189	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—HMOX1—esophageal cancer	1.27e-05	0.000187	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NOS3—esophageal cancer	1.22e-05	0.00018	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.2e-05	0.000177	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.19e-05	0.000176	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.18e-05	0.000174	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.14e-05	0.000168	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.13e-05	0.000166	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PTGS2—esophageal cancer	1.12e-05	0.000165	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.11e-05	0.000163	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ENO1—esophageal cancer	1.07e-05	0.000158	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.07e-05	0.000158	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PSME1—esophageal cancer	1.05e-05	0.000155	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PSME2—esophageal cancer	1.05e-05	0.000155	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.01e-05	0.000149	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.92e-06	0.000146	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.71e-06	0.000143	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—EP300—esophageal cancer	9.3e-06	0.000137	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.1e-06	0.000134	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.55e-06	0.000126	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CREBBP—esophageal cancer	8.13e-06	0.00012	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.8e-06	0.000115	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.49e-06	0.00011	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.34e-06	0.000108	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NOS3—esophageal cancer	7.28e-06	0.000107	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PIK3CA—esophageal cancer	6.88e-06	0.000101	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PTGS2—esophageal cancer	6.65e-06	9.8e-05	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.49e-06	9.56e-05	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NOS3—esophageal cancer	5.81e-06	8.56e-05	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—EP300—esophageal cancer	5.53e-06	8.15e-05	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.31e-06	7.83e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.01e-06	7.38e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NOS3—esophageal cancer	4.48e-06	6.6e-05	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—EP300—esophageal cancer	4.42e-06	6.51e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.1e-06	6.04e-05	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.09e-06	6.03e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—EP300—esophageal cancer	3.41e-06	5.02e-05	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.27e-06	4.81e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.52e-06	3.72e-05	CbGpPWpGaD
